NCPC: Wholly-owned subsidiary receives approval notice for the listing application of Cefoperazone chemical raw materials

NCPC announced that its wholly-owned subsidiary Hebei Huamin Pharmaceutical Co., Ltd. has received the "Approval Notice for the Listing Application of Cefprozil" issued by the National Medical Products Administration. Cefprozil is a second-generation cephalosporin antibiotic that has advantages such as strong antibacterial activity, resistance to penicillinase, and good clinical efficacy, and can be used to treat bronchitis or other bacterial infections